Company news
SenzaGen AB news in 2026
SenzaGen AB's news releases, calls and decks from 2026, newest first.
Invitation to a webcast presentation regarding SenzaGen's acquisition of Alcyomics
October 28, 2026
SenzaGen acquires Alcyomics, a leading UK-based provider of non-animal immunotoxicology solutions for drug development
October 28, 2026
SenzaGen interim report January-June 2026 | Continued strong development in Q2 2026 - 13% growth with positive cash flow
August 20, 2026
SenzaGen’s interim report January–June 2026 | Continued strong development in Q2 2026 – 13% growth with positive cash flow
August 20, 2026
SenzaGen’s subsidiary receives two orders within non-animal testing with a total value of SEK 2.4 million
June 9, 2026
SenzaGen’s interim report January–March 2026 | 10% sales growth alongside increased attention to non-animal methods
May 12, 2026
SenzaGen’s Annual Report 2025 published
April 21, 2026
SenzaGen’s subsidiary receives strategically important order
April 15, 2026
NOTICE OF ANNUAL GENERAL MEETING OF SENZAGEN AB (Publ)
April 8, 2026
SenzaGen wins new global cosmetics group as customer
March 30, 2026
SenzaGen to present strong GARD®skin data at the world’s largest toxicology conference together with leading industry partners
March 17, 2026
SenzaGen carries out a directed issue of approximately SEK 17.5 million to the institutional investor Eiffel Investment Group
February 13, 2026